• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同源二聚体 SARS-CoV-2 主蛋白酶的变构作用。

Allostery in homodimeric SARS-CoV-2 main protease.

机构信息

Department of Chemical Sciences, University of Padova, via F. Marzolo 1, 35131, Padova, Italy.

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, via F. Marzolo 5, 35131, Padova, Italy.

出版信息

Commun Biol. 2024 Nov 4;7(1):1435. doi: 10.1038/s42003-024-07138-w.

DOI:10.1038/s42003-024-07138-w
PMID:39496839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11535432/
Abstract

Many enzymes work as homodimers with two distant catalytic sites, but the reason for this choice is often not clear. For the main protease M of SARS-CoV-2, dimerization is essential for function and plays a regulatory role during the coronaviral replication process. Here, to analyze a possible allosteric mechanism, we use X-ray crystallography, native mass spectrometry, isothermal titration calorimetry, and activity assays to study the interaction of M with three peptide substrates. Crystal structures show how the plasticity of M is exploited to face differences in the sequences of the natural substrates. Importantly, unlike in the free form, the M dimer in complex with these peptides is asymmetric and the structures of the substrates nsp5/6 and nsp14/15 bound to a single subunit show allosteric communications between active sites. We identified arginines 4 and 298 as key elements in the transition from symmetric to asymmetric dimers. Kinetic data allowed the identification of positive cooperativity based on the increase in the processing efficiency (kinetic allostery) and not on the better binding of the substrates (thermodynamic allostery). At the physiological level, this allosteric behavior may be justified by the need to regulate the processing of viral polyproteins in time and space.

摘要

许多酶以具有两个遥远催化位点的同源二聚体形式发挥作用,但这种选择的原因通常不清楚。对于 SARS-CoV-2 的主要蛋白酶 M,二聚化对于功能至关重要,并在冠状病毒复制过程中发挥调节作用。在这里,为了分析可能的变构机制,我们使用 X 射线晶体学、天然质谱、等温滴定量热法和活性测定来研究 M 与三种肽底物的相互作用。晶体结构显示了 M 的可塑性如何被利用来应对天然底物序列的差异。重要的是,与游离形式不同,与这些肽结合的 M 二聚体是不对称的,并且与单个亚基结合的 nsp5/6 和 nsp14/15 底物的结构显示出活性位点之间的变构通讯。我们确定精氨酸 4 和 298 是从对称二聚体向不对称二聚体转变的关键因素。动力学数据允许基于加工效率的增加(动力学变构)而不是底物更好的结合(热力学变构)来识别正协同作用。在生理水平上,这种变构行为可能是由及时和空间调节病毒多蛋白加工的需要所证明的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/d483a5037eee/42003_2024_7138_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/04433ef3d17b/42003_2024_7138_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/f2733b589b6a/42003_2024_7138_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/f7df941beaf6/42003_2024_7138_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/0b8777e3ff1b/42003_2024_7138_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/9d5c848b1e84/42003_2024_7138_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/a4655155c67e/42003_2024_7138_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/c4a2384999a0/42003_2024_7138_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/a7a74bb2a866/42003_2024_7138_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/91c51e2bfd0e/42003_2024_7138_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/c919b0806745/42003_2024_7138_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/be55ed48f653/42003_2024_7138_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/eac52ed5d677/42003_2024_7138_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/d483a5037eee/42003_2024_7138_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/04433ef3d17b/42003_2024_7138_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/f2733b589b6a/42003_2024_7138_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/f7df941beaf6/42003_2024_7138_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/0b8777e3ff1b/42003_2024_7138_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/9d5c848b1e84/42003_2024_7138_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/a4655155c67e/42003_2024_7138_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/c4a2384999a0/42003_2024_7138_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/a7a74bb2a866/42003_2024_7138_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/91c51e2bfd0e/42003_2024_7138_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/c919b0806745/42003_2024_7138_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/be55ed48f653/42003_2024_7138_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/eac52ed5d677/42003_2024_7138_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee0f/11535432/d483a5037eee/42003_2024_7138_Fig13_HTML.jpg

相似文献

1
Allostery in homodimeric SARS-CoV-2 main protease.同源二聚体 SARS-CoV-2 主蛋白酶的变构作用。
Commun Biol. 2024 Nov 4;7(1):1435. doi: 10.1038/s42003-024-07138-w.
2
Allosteric Inhibition of the SARS-CoV-2 Main Protease: Insights from Mass Spectrometry Based Assays*.基于质谱分析的 SARS-CoV-2 主要蛋白酶别构抑制作用的研究进展*。
Angew Chem Int Ed Engl. 2020 Dec 21;59(52):23544-23548. doi: 10.1002/anie.202010316. Epub 2020 Oct 15.
3
Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL main protease (Mpro) from proteomic identification of P6-P6' active site specificity.通过蛋白质组学鉴定 P6-P6' 活性位点特异性优化 SARS-CoV-2 3CL 主要蛋白酶(Mpro)的淬灭荧光肽底物
J Virol. 2024 Jun 13;98(6):e0004924. doi: 10.1128/jvi.00049-24. Epub 2024 May 14.
4
Kinetic comparison of all eleven viral polyprotein cleavage site processing events by SARS-CoV-2 main protease using a linked protein FRET platform.利用连接蛋白荧光共振能转移平台对 SARS-CoV-2 主蛋白酶的所有 11 种病毒多蛋白切割位点加工事件进行动力学比较。
J Biol Chem. 2024 Jun;300(6):107367. doi: 10.1016/j.jbc.2024.107367. Epub 2024 May 15.
5
Allosteric Regulation of 3CL Protease of SARS-CoV-2 and SARS-CoV Observed in the Crystal Structure Ensemble.SARS-CoV-2 和 SARS 冠状病毒 3CL 蛋白酶的别构调节作用在晶体结构组合中观察到。
J Mol Biol. 2021 Dec 3;433(24):167324. doi: 10.1016/j.jmb.2021.167324. Epub 2021 Oct 27.
6
Crystal structures of coronaviral main proteases in complex with the non-covalent inhibitor X77.冠状病毒主蛋白酶与非共价抑制剂 X77 复合物的晶体结构。
Int J Biol Macromol. 2024 Sep;276(Pt 1):133706. doi: 10.1016/j.ijbiomac.2024.133706. Epub 2024 Jul 7.
7
Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300.通过半胱氨酸 300 的谷胱甘肽化实现对 SARS-CoV-2 主要蛋白酶的二聚化和活性的调节。
mBio. 2021 Aug 31;12(4):e0209421. doi: 10.1128/mBio.02094-21. Epub 2021 Aug 17.
8
Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.配体诱导的中东呼吸综合征(MERS)冠状病毒nsp5蛋白酶(3CLpro)二聚化:对nsp5调控及抗病毒药物开发的启示
J Biol Chem. 2015 Aug 7;290(32):19403-22. doi: 10.1074/jbc.M115.651463. Epub 2015 Jun 8.
9
SARS-CoV-2 M inhibitors and activity-based probes for patient-sample imaging.SARS-CoV-2 M 抑制剂和基于活性的探针用于患者样本成像。
Nat Chem Biol. 2021 Feb;17(2):222-228. doi: 10.1038/s41589-020-00689-z. Epub 2020 Oct 22.
10
Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface.基于配体的虚拟筛选和小分子盲对接揭示了 SARS-CoV-2 主蛋白酶二聚体界面上的一个可能的靶位。
Comput Biol Chem. 2020 Dec;89:107372. doi: 10.1016/j.compbiolchem.2020.107372. Epub 2020 Sep 5.

引用本文的文献

1
Inhibition of dimeric SARS-CoV-2 Mpro displays positive cooperativity and a mixture of covalent and non-covalent binding.二聚体严重急性呼吸综合征冠状病毒3C样蛋白酶(SARS-CoV-2 Mpro)的抑制表现出正协同性以及共价和非共价结合的混合情况。
iScience. 2025 May 28;28(7):112773. doi: 10.1016/j.isci.2025.112773. eCollection 2025 Jul 18.
2
The Dynamical Asymmetry in SARS-CoV2 Protease Reveals the Exchange Between Catalytic Activity and Stability in Homodimers.新型冠状病毒蛋白酶中的动力学不对称揭示了同二聚体中催化活性与稳定性之间的交换。
Molecules. 2025 Mar 22;30(7):1412. doi: 10.3390/molecules30071412.
3
In vitro enzymatic and cell culture assays for SARS-CoV-2 main protease interaction with ambenonium.

本文引用的文献

1
Visualizing the Active Site Oxyanion Loop Transition Upon Ensitrelvir Binding and Transient Dimerization of SARS-CoV-2 Main Protease.可视化恩赛特韦结合后 SARS-CoV-2 主蛋白酶活性位点氧阴离子环跃迁和瞬时二聚化。
J Mol Biol. 2024 Jul 1;436(13):168616. doi: 10.1016/j.jmb.2024.168616. Epub 2024 May 16.
2
Unexpected Single-Ligand Occupancy and Negative Cooperativity in the SARS-CoV-2 Main Protease.新冠病毒主蛋白酶的单配体占据和负协同作用的意外发现。
J Chem Inf Model. 2024 Feb 12;64(3):892-904. doi: 10.1021/acs.jcim.3c01497. Epub 2023 Dec 5.
3
Bayesian Inference Elucidates the Catalytic Competency of the SARS-CoV-2 Main Protease 3CL.
用于研究SARS-CoV-2主要蛋白酶与氨苯铵相互作用的体外酶学和细胞培养分析
Sci Rep. 2025 Mar 27;15(1):10606. doi: 10.1038/s41598-025-94283-9.
贝叶斯推断阐明了 SARS-CoV-2 主要蛋白酶 3CL 的催化能力。
Anal Chem. 2023 Oct 10;95(40):14981-14989. doi: 10.1021/acs.analchem.3c02459. Epub 2023 Sep 26.
4
Dynamical Nonequilibrium Molecular Dynamics Simulations Identify Allosteric Sites and Positions Associated with Drug Resistance in the SARS-CoV-2 Main Protease.动力学非平衡分子动力学模拟确定了与SARS-CoV-2主要蛋白酶耐药性相关的变构位点和位置。
JACS Au. 2023 Jun 7;3(6):1767-1774. doi: 10.1021/jacsau.3c00185. eCollection 2023 Jun 26.
5
The main protease of SARS-CoV-2 cleaves histone deacetylases and DCP1A, attenuating the immune defense of the interferon-stimulated genes.SARS-CoV-2 的主要蛋白酶可切割组蛋白去乙酰化酶和 DCP1A,从而削弱干扰素刺激基因的免疫防御。
J Biol Chem. 2023 Mar;299(3):102990. doi: 10.1016/j.jbc.2023.102990. Epub 2023 Feb 8.
6
Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance.定义 SARS-CoV-2 主蛋白酶的底物信封,以预测和避免耐药性。
Nat Commun. 2022 Jun 21;13(1):3556. doi: 10.1038/s41467-022-31210-w.
7
Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2.关键二聚体界面残基影响 SARS-CoV-2 的主要蛋白酶 3CLpro 的催化活性。
J Biol Chem. 2022 Jun;298(6):102023. doi: 10.1016/j.jbc.2022.102023. Epub 2022 May 11.
8
Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2.SARS-CoV-2 主蛋白酶复制酶多蛋白切割和底物特异性的结构基础。
Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2117142119. doi: 10.1073/pnas.2117142119. Epub 2022 Apr 5.
9
A new inactive conformation of SARS-CoV-2 main protease.严重急性呼吸综合征冠状病毒2型主要蛋白酶的一种新的无活性构象。
Acta Crystallogr D Struct Biol. 2022 Mar 1;78(Pt 3):363-378. doi: 10.1107/S2059798322000948. Epub 2022 Feb 21.
10
Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor.通过过渡态类似物抑制剂调节 SARS-CoV-2 主蛋白酶的单体-二聚体平衡和催化活性。
Commun Biol. 2022 Mar 1;5(1):160. doi: 10.1038/s42003-022-03084-7.